Stocks of Johnson & Johnson (NYSE:JNJ) traded higher last session on Wall Street, down -1.70% to $160.88.
JNJ stock price is now -1.47% away from the 50-day moving average and 3.03% away from the 200-day moving average. The market capitalization of the company currently stands at $387.34B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target reduced from $160 to $150, Daiwa Securities Downgraded its rating from Outperform to Neutral for Johnson & Johnson (NYSE: JNJ). , while ‘HSBC Securities’ rates the stock as ‘Buy’
In other news, Decker Robert J, VP Corporate Controller sold 5,635 shares of the company’s stock on Aug 30 ’24. The stock was sold for $930,113 at an average price of $165.06. Upon completion of the transaction, the VP Corporate Controller now directly owns 18,973 shares in the company, valued at $3.05 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 30 ’24, Officer Decker Robert J bought 5,635 shares of the business’s stock. A total of $930,113 was incurred on buying the stock at an average price of $165.06. A total of 0.12% of the company’s stock is owned by insiders.
During the past 12 months, Johnson & Johnson has had a low of $143.13 and a high of $168.85. As of last week, the company has a debt-to-equity ratio of 0.51, a current ratio of 1.03, and a quick ratio of 0.79. According to the stock market information, the enterprise value for the company is $402792382464, which is based on a 26.59 price-to-earnings ratio, a 8.06 price-to-earnings-growth ratio, and a beta of 0.52. The fifty day moving average price for JNJ is $163.2842 and a two-hundred day moving average price translates $156.1513 for the stock.
The latest earnings results from Johnson & Johnson (NYSE: JNJ) was released for 2024-09-29. The net profit margin was 16.75% and return on equity was 20.89% for JNJ. The company reported revenue of $22.47 billion for the quarter, compared to $21.35 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 5.25 percent.
